http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108324962-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1887
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18
filingDate 2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108324962-B
titleOfInvention Preparation method of ferroferric oxide nanoparticles with cluster structure
abstract The invention relates to a preparation method of ferroferric oxide nanoparticles with cluster structures, which comprises the following steps: preparing ultra-small ferroferric oxide nano particles, preparing activated ultra-small ferroferric oxide nano particle solution, and preparing the ferroferric oxide nano particles with cluster structures. The invention is simple, and the prepared Fe 3 O 4 the/Cystamine nano-particles have good stability and biocompatibility, are sensitive to reducing conditions, and can realize T of tumor parts in animal bodies 1 ‑T 2 The bi-modal MR imaging effect can be effectively used as an MR imaging contrast agent, and has industrial and commercial application prospect.
priorityDate 2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID424084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452260893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448397351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61711

Total number of triples: 32.